EHB 1382
SignedHouse
All payers claim database
Modernizing the all payers claim database.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill modernizes Washington’s all-payers claims database by updating how data is collected, secured, and shared to improve transparency in health care costs and quality. It strengthens privacy safeguards, clarifies access rules for different user groups, and requires the Health Care Authority to oversee operations through a competitive contract process for a lead organization.
- Requires the Health Care Authority to oversee the statewide all-payers claims database, including selecting a lead organization through a competitive, conflict-free procurement process.
- Updates data reporting requirements to include medical, pharmacy, and dental claims, with stricter standards for data quality, security, and de-identification using unique identifiers.
- Strengthens privacy protections by limiting access to direct patient identifiers, indirect patient identifiers, and proprietary financial information, and requiring signed data use agreements with strict confidentiality and destruction requirements.
- Mandates public reporting on health care cost and quality, including geographic and demographic disparities, with requirements for provider verification and correction of errors before publication.
- Establishes a five-year evaluation cycle (instead of biennial) led by the Office of Financial Management, assessing database performance, security, and alignment with state agency needs.
Who is affected
- Health insurers and payers — Health plans, insurers, and other entities that provide health coverage must submit claims and enrollment data to the database under updated requirements, and may be subject to new restrictions on serving as lead organization.
- Health care providers and hospitals — Hospitals, clinics, and other providers may benefit from improved transparency tools and benchmarking, but must ensure data accuracy through verification processes before public reporting.
- State agencies and researchers — State agencies (e.g., Medicaid, health benefit exchange), researchers, and third-party administrators gain access to de-identified data for analysis, policy development, and program improvement, under strict confidentiality rules.
- Employers and health plan sponsors — Employers and health plan sponsors (especially self-funded plans) can use aggregated data to evaluate value and cost-effectiveness of health benefits, but cannot access individual-level or proprietary financial data.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
The bill bars health plans, hospitals, providers, and third-party administrators from serving as lead organization, reducing conflicts of interest and increasing the likelihood that database operations prioritize public transparency and system-level analysis over proprietary or institutional gain—benefiting patients, researchers, and public agencies.
HealthcarePeopleRef: Sec. 2(2)(d)(v)The bill strengthens patient privacy by strictly limiting access to direct and indirect identifiers, requiring IRB approval for researcher access, and mandating data use agreements with destruction requirements—benefiting everyday Washingtonians by reducing risks of re-identification, discrimination, and misuse of sensitive health data.
HealthcarePeopleRef: Sec. 4(4)(a)-(c)The bill mandates public reporting on geographic and demographic disparities in care and costs, with requirements for provider verification and correction before publication—benefiting patients, communities, and public agencies by enabling more accurate benchmarking, accountability, and targeted interventions to reduce inequities.
HealthcarePeopleRef: Sec. 4(2)(a)(ii)The bill requires the lead organization to convene advisory committees with stakeholder representation—including consumer organizations—ensuring broader input into database governance and data release policies, which can improve responsiveness to public needs and reduce institutional bias.
HealthcareLean peopleRef: Sec. 2(5)(h)(ii)The bill establishes a five-year evaluation cycle (instead of biennial) led by OFM, with explicit assessment of database responsiveness, data processing efficiency, and communication—benefiting state and local agencies by improving long-term planning, reducing redundant reporting, and ensuring the database remains aligned with evolving program needs.
Local GovernmentPeopleRef: Sec. 6(2)(e)
Potential Concerns (5)
The bill prohibits health plans, hospitals, providers, third-party administrators, and their affiliates from serving as lead organization or being represented on governance/advisory committees unless they are data suppliers—this may reduce competition and innovation in the lead organization role, potentially limiting cost-effective service delivery and increasing long-term contract costs for the state.
Business & EmploymentRef: Sec. 2(5)(h)(ii)The bill requires the lead organization to convene advisory committees with in-state representation from key stakeholders—including large carriers and providers—but does not mandate consumer or public advocacy representation, potentially skewing policy development toward institutional interests over patient or community priorities.
Local GovernmentRef: Sec. 2(5)(h)(i)The bill allows the lead organization to charge fees for reports and data files, but prohibits charging data suppliers (e.g., insurers, employers, providers) except for specific requested outputs—this may shift operational costs toward public or non-profit users (e.g., researchers, local governments), potentially limiting access for smaller or underfunded entities.
Business & EmploymentRef: Sec. 2(5)(h)(ii)The bill does not require independent oversight of the lead organization’s data security practices beyond reporting to Washington Technology Solutions, and does not mandate third-party audits—this could leave data breach risks unmitigated if the lead organization lacks incentives to invest in robust, verifiable security.
Public SafetyLean peopleRef: Sec. 2(5)(h)(ii)The bill requires reports to stratify by demography, income, language, health status, and geography—but only “when feasible with available data”—which may result in inconsistent or incomplete disparity analysis, especially for small or marginalized populations, limiting actionable insights for equity-focused interventions.
HealthcareRef: Sec. 4(2)(a)(ii)
Who Is Most Affected
Health insurers and payers must submit claims and enrollment data under stricter standards and are barred from serving as lead organization or on governance bodies unless they are data suppliers. This increases compliance costs but reduces competitive advantage for large insurers, promoting neutrality in database leadership.
Providers and hospitals benefit from improved transparency tools and benchmarking, but must verify data accuracy before public reporting. While this supports quality improvement, it adds administrative burden—especially for small practices without data teams.
State agencies (e.g., Medicaid, health benefit exchange), researchers, and third-party administrators gain access to de-identified data under strict confidentiality rules, enabling better policy development and evaluation. This improves public program efficiency and research capacity.
Employers and health plan sponsors (especially self-funded) can use aggregated data to evaluate benefit value—but cannot access individual-level or proprietary financial data. This supports cost-containment strategies without exposing trade secrets, benefiting mid- to large employers more than micro-businesses.
Patients and community members benefit from stronger privacy safeguards, public disparity reporting, and conflict-of-interest restrictions on database leadership—reducing risks of discrimination and increasing trust in health data use.